Pharmacy
Biogen Reports First Quarter 2017 Revenues of $2.8 Billion
The FINANCIAL -- Biogen Inc. on Aptil 25 reported first quarter 2017 financial results, including:
Allergan Granted Marketing Authorization by the FDA for TrueTear
The FINANCIAL -- Allergan plc, on April 25 announced that it has been granted marketing authorization from the U.S. Food...
Eli Lilly And Co. Announces 18% Increase In Q1 Profit
The FINANCIAL -- Eli Lilly and Company on April 25 announced financial results for the first quarter of 2017.
Abbott sales, profit propped up by St. Jude acquisition
The FINANCIAL -- Abbott on April 19 announced financial results for the first quarter ended March 31, 2017.
J&J revenue misses on lower-than-expected pharmaceutical sales
The FINANCIAL -- Johnson & Johnson on April 18 announced sales of $17.8 billion for the first quarter of 2017,...
Novartis expands development programs for NASH through clinical collaboration with Allergan
The FINANCIAL -- Novartis announced on April 18 that it has entered into a clinical trial agreement with Allergan plc...
Tagrisso (osimertinib) receives US FDA full approval
The FINANCIAL -- AstraZeneca on March 31 announced that the US Food and Drug Administration (FDA) has granted full approval...
Novo Nordisk resubmits new drug application for fast-acting insulin aspart in the US
The FINANCIAL -- Novo Nordisk on March 29 announced that the company has resubmitted the new drug application (NDA) for...
Sanofi and Regeneron Announce FDA Approval of Dupixent (dupilumab)
The FINANCIAL -- Sanofi and Regeneron Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved Dupixent...
AstraZeneca wins approval for lung cancer pill in China
The FINANCIAL -- AstraZeneca on March 27 announced that the China Food and Drug Administration (CFDA) has granted marketing authorisation...
Lilly and the William Sansum Diabetes Center announce a five-year research collaboration
The FINANCIAL -- Eli Lilly and Company and the William Sansum Diabetes Center have established a research collaboration to improve...
Launch of LINZESS Tablets 0.25mg in Japan
The FINANCIAL -- Astellas Pharma Inc. announced that it launched a guanylate cyclase-C (GC-C) receptor agonist, LINZESS Tablets for irritable...
Bristol-Myers, CytomX Extend Deal To Find Probody Therapeutics To Treat Cancer
The FINANCIAL -- Bristol-Myers Squibb Company and CytomX Therapeutics, Inc., a biopharmaceutical company developing investigational Probody therapeutics for the treatment...
AstraZeneca and Circassia enter strategic collaboration in respiratory disease
The FINANCIAL -- AstraZeneca on March 17 announced it has entered a strategic collaboration with Circassia Pharmaceuticals plc, a respiratory...
Pfizer Announces Approval By The China Food And Drug Administration Of XELJANZ
The FINANCIAL -- Pfizer China announced on March 15 that it has received approval from the Chinese Food and Drug...
ADVERTISEMENT
Popular Last 24h
-
Zebra dies after ‘incident’with rhino at zoo
-
Government Contractor Agrees to Pay $1M to Resolve False Claims Act Allegations for Submitting Fraudulent Bids on Prime Vendor Contracts
-
Giant Pandas Will Make Their Public Debut Jan. 24 at Smithsonian’s National Zoo and Conservation Biology Institute
-
Gerald Durrell’s Centenary: a year of celebrations starts today
-
ICE Acquires the American Financial Exchange (AFX)
-
Trump sentenced in felony “hush money” case, released with no restrictions
-
Ampersand wins £22m five-year contract at London Zoo
LATEST POSTS
LATESTINTERVIEWS
ADVERTISEMENT
